Summitry LLC boosted its position in Rentokil Initial PLC (NYSE:RTO – Free Report) by 1.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,475,957 shares of the company’s stock after acquiring an additional 25,170 shares during the quarter. Rentokil Initial accounts for 1.8% of Summitry LLC’s holdings, making the stock its 21st largest holding. Summitry LLC owned 0.29% of Rentokil Initial worth $43,482,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. GAMMA Investing LLC grew its stake in shares of Rentokil Initial by 76.5% during the fourth quarter. GAMMA Investing LLC now owns 1,232 shares of the company’s stock worth $36,000 after buying an additional 534 shares during the last quarter. Smartleaf Asset Management LLC grew its stake in shares of Rentokil Initial by 171.0% during the third quarter. Smartleaf Asset Management LLC now owns 1,726 shares of the company’s stock worth $43,000 after buying an additional 1,089 shares during the last quarter. EverSource Wealth Advisors LLC grew its stake in shares of Rentokil Initial by 296.3% during the fourth quarter. EverSource Wealth Advisors LLC now owns 1,954 shares of the company’s stock worth $58,000 after buying an additional 1,461 shares during the last quarter. IFP Advisors Inc grew its stake in shares of Rentokil Initial by 53.8% during the third quarter. IFP Advisors Inc now owns 1,972 shares of the company’s stock worth $50,000 after buying an additional 690 shares during the last quarter. Finally, Tucker Asset Management LLC bought a new stake in shares of Rentokil Initial during the fourth quarter worth $84,000. Institutional investors own 9.91% of the company’s stock.
Wall Street Analyst Weigh In
A number of analysts have weighed in on RTO shares. Zacks Research raised shares of Rentokil Initial from a “strong sell” rating to a “hold” rating in a research note on Monday, May 4th. Oppenheimer boosted their target price on shares of Rentokil Initial from $30.00 to $35.00 and gave the stock an “outperform” rating in a research note on Tuesday, March 10th. Deutsche Bank Aktiengesellschaft cut shares of Rentokil Initial from a “buy” rating to a “hold” rating in a research note on Tuesday, February 24th. UBS Group raised shares of Rentokil Initial from a “neutral” rating to a “buy” rating in a research note on Thursday, March 12th. Finally, Rothschild & Co Redburn raised shares of Rentokil Initial from a “sell” rating to a “neutral” rating in a research note on Wednesday, March 11th. One investment analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, four have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, Rentokil Initial has an average rating of “Moderate Buy” and a consensus price target of $34.50.
Rentokil Initial Stock Performance
Shares of NYSE:RTO opened at $31.38 on Tuesday. The firm’s fifty day moving average is $32.64 and its 200-day moving average is $30.91. The company has a current ratio of 1.16, a quick ratio of 1.07 and a debt-to-equity ratio of 0.76. Rentokil Initial PLC has a 52 week low of $22.72 and a 52 week high of $34.67.
Rentokil Initial Dividend Announcement
The firm also recently declared a dividend, which was paid on Tuesday, May 19th. Stockholders of record on Friday, April 10th were issued a dividend of $0.412 per share. This represents a dividend yield of 245.0%. The ex-dividend date was Friday, April 10th.
Rentokil Initial Company Profile
Rentokil Initial PLC is a global business services company specializing in pest control, hygiene and workwear services. Headquartered in Crawley, West Sussex, United Kingdom, the company delivers outsourced solutions designed to protect people, preserve assets and enhance workplaces for both commercial and residential customers.
Under the Rentokil Pest Control brand, the company offers services ranging from routine inspections and treatment of insects, rodents and birds to specialised programmes for food manufacturing and healthcare environments.
Featured Articles
- Five stocks we like better than Rentokil Initial
- SpaceX Gets the Attention, But These 4 Stocks Could Get the Returns
- Microsoft Stock Discount May Be Ending as AI Catalysts Build
- Apparel Earnings Winners and Losers: Ralph Lauren Takes Off
- Why Walmart, Target and TJX Got Such Different Reactions After Earnings
Receive News & Ratings for Rentokil Initial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rentokil Initial and related companies with MarketBeat.com's FREE daily email newsletter.
